uppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY issue-copyright-statement © The Author(s) 2019 Background The incidence of thyroid cancer, particularly well-differentiated thyroid carcinoma (WDTC), shows an increasing trend globally.
← all excerpts
Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.
1
—
—